Mycosis fungoides is a type of cutaneous T-cell lymphoma characterized by the proliferation of malignant T-lymphocytes in the skin. When classified as 'in remission,' it indicates that the disease is currently not active, which is clinically significant for treatment planning and monitoring. The ICD-10 Code C84.0A facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track patient outcomes and resource utilization.
ICD-10 Code C84.0A specifically denotes Mycosis fungoides that is currently in remission. This condition represents a stage of cutaneous T-cell lymphoma where the signs and symptoms have subsided, indicating a positive response to treatment. This code should be used in clinical documentation and billing when a patient has a confirmed diagnosis of Mycosis fungoides and is not experiencing active disease.
Mycosis fungoides is a chronic skin condition that requires ongoing medical attention due to its potential to progress. The remission phase is crucial as it signifies a reduction or absence of disease activity, allowing for continued monitoring and management. Understanding this condition's clinical features is essential for effective treatment and follow-up.
ICD-10 Code C84.0A is utilized in SOAP notes to document the patient's remission status, guiding clinical workflows. It plays a vital role in recording symptoms, assessments, and treatment plans, ensuring comprehensive care in both acute and chronic settings.
In SOAP notes, ICD-10 Code C84.0A connects subjective patient reports and objective clinical findings to a formal diagnosis of Mycosis fungoides in remission. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of Mycosis fungoides in remission focuses on maintaining skin health and monitoring for any signs of recurrence. Treatment strategies may include topical therapies and regular follow-ups.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.0A is crucial for accurate billing in hospital, ER, or infectious disease care settings, reflecting the patient's remission status.
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, low complexity. |
| 11100 | Biopsy of skin, subcutaneous tissue, or mucous membrane. |
| 99214 | Established patient office visit, moderate complexity. |
Common Questions About Using ICD-10 Code C84.0A for Mycosis fungoides, in remission
What does it mean for Mycosis fungoides to be in remission?
Remission in Mycosis fungoides indicates that the disease is not currently active, with no new lesions or symptoms present. This status is crucial for ongoing management and monitoring.
How often should patients with Mycosis fungoides in remission be monitored?
Patients in remission should have regular follow-up appointments, typically every 3 to 6 months, to monitor for any signs of recurrence or changes in skin condition.
Can Mycosis fungoides in remission recur?
Yes, Mycosis fungoides can recur even after a period of remission. Continuous monitoring is essential to detect any new symptoms early.
What treatments are available for Mycosis fungoides in remission?
Treatment during remission focuses on maintaining skin health, which may include topical therapies, regular dermatological assessments, and patient education on skin care.
Clinical Notes
SOAP notes
DAP notes
AI medical notes